Physician profile
Benessa Mitchell Sutton
NPI 1124679683
$914.95
in general payments reported to CMS, 2019-2025
15 companies · $75.72 in 2025
The $75.72 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $398 · 2023: $236 · 2025: $75.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $369.24 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $105.55 | 2021-2023 | |
| Lilly USA, LLC | $72.80 | 2022-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $59.53 | 2021 | |
| Exact Sciences Corporation | $58.10 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $51.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.62 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.02 | 2022 | |
| Hologic Sales and Service, LLC | $21.86 | 2025 | Aptima |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.76 | 2022 | |
| Corium, LLC | $17.27 | 2023 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.03 | 2021 | |
| Amarin Pharma, INC. | $16.30 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.69 | 2023 | Crysvita |
| Glaxosmithkline, LLC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benessa Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.